Wire Stories

Category Added in a WPeMatico Campaign

RRVL_logo

KKR to Invest ₹ 2,069.50 Crore in Reliance Retail Ventures Limited at an Equity Value of ₹ 8.361 Lakh Crore; to Increase Equity Stake From 1.17% to 1.42%

KKR’S FOLLOW-ON INVESTMENT IN RRVL REAFFIRMS ITS BELIEF IN THE MARKET OPPORTUNITY AND RELIANCE RETAIL'S BUSINESS MODEL MUMBAI, India--(BUSINESS WIRE)--Reliance...

logo-19

Japan Youth Gamers Report 2023: Most Youth Gamers Play on Console (72%) Followed by Mobile (64%) and PC (15%) – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Japan Youth Gamers" report from Niko Partners, Inc. has been added to ResearchAndMarkets.com's offering. The comprehensive report examines...

logo-17

Regional Overview: Asia Pacific Takes Lead in Global Front Open Shipping Box (FOSB) Market Growth with Projected CAGR Exceeding 10.22% – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Front Open Shipping Box Market, By Type; By Application-Estimation & Forecast, 2017-2030" report has been added to...

logo-16

Revolutionizing Armoured Vehicle Safety: Active and Passive Protection Systems Explored in Comprehensive 2023 Report – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Protection Systems for Land vehicles - Market and Technology Forecast to 2031" report has been added to ResearchAndMarkets.com's...

BMS_LOGO

Six-Year Outcomes from Phase 3 CheckMate -227 Trial Show Durable, Long-Term Survival with Opdivo (nivolumab) Plus Yervoy (ipilimumab) in the First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer

3472696_BrandSymbol_Dakiyama_Rd

Takeda Announces Positive Topline Results from Phase 2b Study Evaluating TAK-279, a Highly Selective Oral TYK2 Inhibitor, for the Treatment of Active Psoriatic Arthritis

− Topline Results for TAK-279 Show that a Significantly Greater Proportion of Psoriatic Arthritis Patients Achieved at Least an ACR20...